Beam Therapeutics: Q3 Earnings Insights

Beam Therapeutics BEAM reported its Q3 earnings results on Wednesday, November 8, 2023 at 06:30 AM.

Here's what investors need to know about the announcement.

Beam Therapeutics beat estimated earnings by 8.96%, reporting an EPS of $-1.22 versus an estimate of $-1.34.

Revenue was up $1.39 million from the same period last year.

Last quarter the company beat on EPS by $0.34 which was followed by a 0.53% drop in the share price the next day.

Here's a look at Beam Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-1.42	-1.34	-1.33	-1.31
EPS Actual	-1.08	-1.33	-0.54	-1.56
Revenue Estimate	18.05M	14.08M	12.53M	7.94M
Revenue Actual	20.12M	24.21M	20.04M	15.80M

To track all earnings releases for Beam Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar